Eric Pauwels
CIK 1323212 · CHIEF BUSINESS OFFICER · last filed 2026-06-12
Eric Pauwels is a CHIEF BUSINESS OFFICER who has filed 74 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for PTCT, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$12.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.82M
3
74
-$12.62M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTCT | CHIEF BUSINESS OFFICER | 90,977 | $74.84 | $6.81M | -$12.62M | 36 | 2026-06-12 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | President, NPS Pharma Int'l | 0 | — | — | $0 | 11 | 2015-02-24 |
| ARAY | SVP Chief Marketing Officer | 30,000 | $0.24 | $7.2K | $0 | 1 | 2011-03-01 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | PTCT | Mixed | −3,711 | -$1.28M | EDGAR |
| 2026-06-10 | PTCT | Notice (144) | −21,277 | -$1.60M | EDGAR |
| 2026-02-20 | PTCT | Sell (S) | −3,019 | -$209.4K | EDGAR |
| 2026-02-18 | PTCT | Notice (144) | −3,019 | -$209.4K | EDGAR |
| 2026-01-12 | PTCT | Sell (S) | −7,348 | -$565.9K | EDGAR |
| 2026-01-09 | PTCT | Notice (144) | −2,746 | -$213.9K | EDGAR |
| 2026-01-08 | PTCT | Notice (144) | −3,148 | -$240.9K | EDGAR |
| 2026-01-08 | PTCT | Notice (144) | −1,454 | -$111.2K | EDGAR |
| 2026-01-08 | PTCT | Sell (S) | −3,141 | -$242.4K | EDGAR |
| 2026-01-07 | PTCT | Notice (144) | −1,352 | -$104.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.